An Exploratory Study of Pembrolizumab Plus Entinostat in Non-Inflamed Stage III/IV Melanoma

NCT03765229 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

DRUG: Entinostat
DRUG: Pembrolizumab

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]